NOACs in atrial fibrillation: Current landscape in clinical practice

3 September 2019 (13:10 - 13:20)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Professor Nicolas Danchin

Saint Joseph Hospital, Paris (France)

4 More presentations in this session

Presentation thumbnail

Achievements with NOACs in NVAF to date

Professor M. Gilard (Brest, FR)

Presentation thumbnail

Exploring evidence for long-standing questions

Professor R. Lopes (Durham, US)

Presentation thumbnail

Management of atrial fibrillation patients with concomitant need for antiplatelet therapy: Is the dilemma resolved?

Professor P. Sinnaeve (Leuven, BE)

Presentation thumbnail

Questions and answers

Professor M. Gilard (Brest, FR) Professor R. Lopes (Durham, US)

Access the full session

Session thumbnail

Improving outcomes with non-vitamin K antagonist oral anticoagulants (NOACs): Focus on atrial fibrillation patients with acute coronary syndrome (ACS) and/or undergoing percutaneous coronary intervention (PCI)

The Event

ESC Congress 2019

3 September 2019 13:10 CET

You may be interested in

Webinar

Are NOACs already outdated? New trends in anticoagulation therapy

12 December 2022

Congress Presentation

Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program

27 August 2021

Congress Presentation

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients with differential duration of treatment: an analysis of the ARISTOPHANES study

2 September 2019

Congress Presentation

What do real-world analyses tell us about NOACs?

28 August 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources